WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
Black sailor killed at Pearl Harbor FINALLY identified more than eight decades after 19DeSmith stops 32 shots and Canucks sweep season series with 3Demand recovery to be priority4th China CrossInvesting in the new: foreign firms tapping into China's emerging industriesGreen shift places remote northeastern Chinese city in spotlightChina's innovative drugs gain momentum in global expansion effortsChina's online transactions rise during Spring Festival holidayChina's development brings new opportunities for global growthChina expands transport network to facilitate high
2.5994s , 6501.515625 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Cultural Compass news portal